How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?

AIMS: To assess the cardiovascular disease (CVD) risk of people with screen-detected Type 2 diabetes and to estimate the risk reduction achievable through early intensive pharmacological intervention. METHODS: In ADDITION-Cambridge, diabetic patients were identified among people aged 40-69 years thr...

Full description

Bibliographic Details
Main Authors: Echouffo-Tcheugui, J, Sargeant, L, Prevost, A, Williams, K, Barling, R, Butler, R, Fanshawe, T, Kinmonth, A, Wareham, N, Griffin, S
Format: Journal article
Language:English
Published: 2008
_version_ 1826288638455971840
author Echouffo-Tcheugui, J
Sargeant, L
Prevost, A
Williams, K
Barling, R
Butler, R
Fanshawe, T
Kinmonth, A
Wareham, N
Griffin, S
author_facet Echouffo-Tcheugui, J
Sargeant, L
Prevost, A
Williams, K
Barling, R
Butler, R
Fanshawe, T
Kinmonth, A
Wareham, N
Griffin, S
author_sort Echouffo-Tcheugui, J
collection OXFORD
description AIMS: To assess the cardiovascular disease (CVD) risk of people with screen-detected Type 2 diabetes and to estimate the risk reduction achievable through early intensive pharmacological intervention. METHODS: In ADDITION-Cambridge, diabetic patients were identified among people aged 40-69 years through a stepwise screening procedure including a risk score, random and fasting capillary blood glucose, HbA(1c) and oral glucose tolerance test. In those without prior macrovascular disease, 10-year CVD risk was computed using UK Prospective Diabetes Study (UKPDS) and Framingham engines. The absolute risk reduction achievable and its plausible range were predicted using relative risk reductions for individual therapies from published trials and sensitivity analysis. RESULTS: Of the 867 individuals with undiagnosed diabetes, 19% had pre-existing CVD, 97% were overweight or obese, 86% had hypertension, 75% had dyslipidaemia, 20% had microalbuminuria and 18% were smokers. Of those with hypertension, 35% were not prescribed drugs and 42% were suboptimally treated. Of participants with dyslipidaemia, 68% were not prescribed medications and 22% were poorly controlled. Median 10-year CVD risk was 34.0%[interquartile range (IQR) 26.2-44.6] in men and 21.5% (IQR 15.7-28.7) in women using the UKPDS engine; 38.6% (IQR 27.8-53.0) in men and 24.6% (IQR 17.2-32.9) in women using Framingham equations. In the most conservative scenario (no additive effect of therapies), the absolute risk reduction achievable through multifactorial therapy ranged from 4.9 to 9.5% (UKPDS) and from 5.4 to 10.5% (Framingham). The corresponding ranges of numbers needed to treat were 11-20 and 10-19. CONCLUSIONS: People with screen-detected diabetes have an adverse cardiovascular risk profile, which is potentially modifiable through application of existing treatment recommendations.
first_indexed 2024-03-07T02:16:44Z
format Journal article
id oxford-uuid:a2824b36-92a5-496d-91c3-2d2ec664cffb
institution University of Oxford
language English
last_indexed 2024-03-07T02:16:44Z
publishDate 2008
record_format dspace
spelling oxford-uuid:a2824b36-92a5-496d-91c3-2d2ec664cffb2022-03-27T02:20:35ZHow much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:a2824b36-92a5-496d-91c3-2d2ec664cffbEnglishSymplectic Elements at Oxford2008Echouffo-Tcheugui, JSargeant, LPrevost, AWilliams, KBarling, RButler, RFanshawe, TKinmonth, AWareham, NGriffin, SAIMS: To assess the cardiovascular disease (CVD) risk of people with screen-detected Type 2 diabetes and to estimate the risk reduction achievable through early intensive pharmacological intervention. METHODS: In ADDITION-Cambridge, diabetic patients were identified among people aged 40-69 years through a stepwise screening procedure including a risk score, random and fasting capillary blood glucose, HbA(1c) and oral glucose tolerance test. In those without prior macrovascular disease, 10-year CVD risk was computed using UK Prospective Diabetes Study (UKPDS) and Framingham engines. The absolute risk reduction achievable and its plausible range were predicted using relative risk reductions for individual therapies from published trials and sensitivity analysis. RESULTS: Of the 867 individuals with undiagnosed diabetes, 19% had pre-existing CVD, 97% were overweight or obese, 86% had hypertension, 75% had dyslipidaemia, 20% had microalbuminuria and 18% were smokers. Of those with hypertension, 35% were not prescribed drugs and 42% were suboptimally treated. Of participants with dyslipidaemia, 68% were not prescribed medications and 22% were poorly controlled. Median 10-year CVD risk was 34.0%[interquartile range (IQR) 26.2-44.6] in men and 21.5% (IQR 15.7-28.7) in women using the UKPDS engine; 38.6% (IQR 27.8-53.0) in men and 24.6% (IQR 17.2-32.9) in women using Framingham equations. In the most conservative scenario (no additive effect of therapies), the absolute risk reduction achievable through multifactorial therapy ranged from 4.9 to 9.5% (UKPDS) and from 5.4 to 10.5% (Framingham). The corresponding ranges of numbers needed to treat were 11-20 and 10-19. CONCLUSIONS: People with screen-detected diabetes have an adverse cardiovascular risk profile, which is potentially modifiable through application of existing treatment recommendations.
spellingShingle Echouffo-Tcheugui, J
Sargeant, L
Prevost, A
Williams, K
Barling, R
Butler, R
Fanshawe, T
Kinmonth, A
Wareham, N
Griffin, S
How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title_full How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title_fullStr How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title_full_unstemmed How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title_short How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?
title_sort how much might cardiovascular disease risk be reduced by intensive therapy in people with screen detected diabetes
work_keys_str_mv AT echouffotcheuguij howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT sargeantl howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT prevosta howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT williamsk howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT barlingr howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT butlerr howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT fanshawet howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT kinmontha howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT warehamn howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes
AT griffins howmuchmightcardiovasculardiseaseriskbereducedbyintensivetherapyinpeoplewithscreendetecteddiabetes